Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Brian D. Kent, G d’Ancona, Mariana Fernandes, Linda Green, Cris Roxas, Louise Thomson, Alexandra M. Nanzer, Joanne Kavanagh, Sangita Agarwal, David J. Jackson
Abstract
<b>Blockade of interleukin-5 with reslizumab appears to have significant oral corticosteroid sparing effects in patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma</b>http://bit.ly/2D2yYSK
Topics & Concepts
Granulomatosis with polyangiitisMedicineEosinophilicCorticosteroidAsthmaDermatologyGastroenterologyInternal medicinePathologyVasculitisDiseaseVasculitis and related conditionsUrticaria and Related ConditionsEosinophilic Disorders and Syndromes